Publication List

Bibliography of Publications

Listed below are the articles published following meetings held by The Macrae Group. For further information regarding particular publications,
please contact us directly.

Ison MG, Mills J, Openshaw P, Zambon M, Osterhaus A, Hayden FG (2002). IV International Symposium: Current Research on Respiratory Viral Infections. Antiviral Research 55, 227-278.

Schmidt AC, Couch RB, Galasso GJ, Hayden FG, Mills J, Murphy RB, Chanock RM (2001). III International Symposium: Current Research on Respiratory Viral Infections. Antiviral Research 50/3, 157-196.

LaBranche CC, Galasso GJ, Moore JP, Bolognesi DP, Hirsch MS, Hammer SM (2001). Collaborative Research Seminar on HIV Entry and Fusion Inhibition: A Review. Antiviral Research 50/2, 95-115.

Munoz FM, Galasso GJ, Gwaltney J, Hayden FG, Murphy B, Webster R, Wright P, Couch RB (2000). II International Symposium on Influenza and other Respiratory Viruses. Antiviral Research 46, 91-124.

Gonzalez-Peralta RP, Galasso GJ, Poynard T, Schalm S, Thomas HC, Wright TL (1999). Summary of the First International Symposium on Viral Hepatitis. Antiviral Research 42, 77-96.

Kaiser L, Couch R, Galasso G, Glezen P, Webster R, Wright P, Hayden FG (1999). First International Symposium on Influenza and other Respiratory Viruses: Summary and Overview. Antiviral Research 42, 149-175.

Ryan D, Bray G, Rossner S, Galasso GJ (1999). Summary of the Symposium on Obesity: New Directions. Obesity Research 7, 303-308.

de Jong MD, Galasso GJ, Gazzard BG, Griffiths PD, Jabs D, Kern ER, Spector SA, Whitley RJ (1998). Summary of the II International Symposium on Cytomegalovirus. Antiviral Research 39, 141-162.

Cohen Stuart J, Boucher CAB, Cooper DA, Galasso GJ, Hayden FG, Richman DD, Spector SA, Thomas HC, Whitley RJ (1998). Summary of the III International Consensus Symposium on Combined Antiviral Therapy. Antiviral Research 38, 75-93.

de Jong MD, Boucher CAB, Danner SA, Gazzard BG, Griffiths PD, Katlama C, Lange JMA, Richman DD, Vella S (1998). Summary of the International Consensus Symposium on Management of HIV, CMV and Hepatitis Virus Infections. Antiviral Research 37, 1-16.

de Jong MD, Boucher CAB, Cooper DA, Galasso GJ, Gazzard BG, Lange JMA, Montaner J, Richman DD, Thomas HC (1997). Summary of the II International Consensus Symposium on Combined Antiviral Therapy and Implications for Future Therapies. Antiviral Research 35, 65-82.

van der Meer JTM, Drew WL, Bowden RA, Galasso GJ, Griffiths PD, Jabs DA, Katlama C, Spector SA, Whitley RJ (1996). Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis of Cytomegalovirus Infection. Antiviral Research 32, 119-140.

de Jong MD, Boucher CAB, Galasso GJ, Hirsch MS, Kern ER, Lange JMA, Richman DD (1996). Consensus Symposium on Combined Antiviral Therapy. Antiviral Research 29, 5-29.

Richman DD (1996). The Implications of Drug Resistance for Strategies of Combination Antiviral Chemotherapy. Antiviral Research 29, 31-33.

Johnson VA (1996). Combination Therapy for HIV-1 Infection-Overview: Preclinical and Clinical Anaylsis of Antiretroviral Combinations. Antiviral Research 29, 35-39.

Shipman C (1996). Analysis of Drug-Drug Interactions: An Overview. Antiviral Research 29, 41-43.

Hayden FG (1996). Combination Antiviral Therapy for Respiratory Virus Infections. Antiviral Research 29, 45-48.

Korba BE (1996). In Vitro Evaluation of Combination Therapies Against Hepatitis B Virus Replication. Antiviral Research 29, 49-51.

St Clair MH, Millard J, Rooney J, Tisdale M, Parry N, Sadler BM, Blum MR, Painter G (1996). In Vitro Antiviral Activity of 141W94 (VX-478) in Combination with Other Antiretroviral Agents. Antiviral Research 29, 53-56.

Kern ER (1996). Role of Animal Models in Selecting Antiviral Combinations for Clinical Studies. Antiviral Research 29, 57-59.

Stals FS, Wagenaar SSc, Kloover JS, Vanagt WYR, Bruggeman CA (1996). Combinations of Ganciclovir and Antibody for Experimental CMV Infections. Antiviral Research 29, 61-64.

Lietman PS (1996). Overview: Issues Concerning the Pharmacology of Multiple Drug Regimens. Antiviral Research 29, 65.

Whitley RJ, Gnann JW Jr, Weiss HL, Soong S-j (1996). Unique Clinical Trial Design: Combination Acyclovir plus Prednisone Therapy of Localized Zoster in the Normal Host. Antiviral Research 29, 67-68.

Jabs DA (1996). Design of Clinical Trials for Drug Combinations: Cytomegalovirus Retinitis – Foscarnet and Ganciclovir. The CMV retinitis retreatment trial. Antiviral Research 29, 69-71.

Pollard RB (1996). CMV Retinitis: Ganciclovir/Monoclonal Antibody. Antiviral Research 29, 73-75.

Dusheiko GM (1996). Summary: Antiviral Treatment of Hepatitis C Virus. Antiviral Research 29, 77-82.

Reichelderfer PS, Coombs RW (1996). Cartesian Coordinate Analysis of Viral Burden and CD4+ Cell Count in HIV Disease: Implications for Clinical Trial Design and Analysis. Antiviral Research 29, 83-86.

Perrin L, Hirschel B (1996). Combination Therapy in Primary HIV Infection. Antiviral Research 29, 87-89.

Vella S, Galluzzo C, Giannini G, Pirillo MF, Duncan I, Jacobsen H, Andreoni M, Sarmati L, Ercoli L (1996). Saquinavir/Zidovudine Combination in Patients with Advanced HIV Infection and no Prior Antiretroviral Therapy: CD4+ Lymphocyte/Plasma RNA Changes, and Emergence of HIV Strains with Reduced Phenotypic Sensitivity. Antiviral Research 29, 91-93.

Jacobsen H, Haenggi M, Ott M, Duncan IB, Andreoni M, Vella S, Mous J (1996). Reduced Sensitivity to Saquinavir: An Update on Genotyping from Phase I/II Trials. Antiviral Research 29, 95-97.

Collier AC, Coombs RW, Schoenfeld DA, Basett R, Baruch A, Corey L (1996). Combination Therapy with Zidovudine, Didanosine and Saquinavir. Antiviral Research 29, 99.

Pollard RB (1996). D4T Nucleoside Combinations for HIV. Antiviral Research 29, 101-104.

Sneller MC (1996). Consensus Symposium on Combined Antiviral Therapy: An Overview of Interferon and IL-2 Combinations for the Treatment of HIV Infection. Antiviral Research 29, 105-109.

Biron F, Lucht F, Peyramond D, Fresard A, Vallet T, Nugier F, Grange J, Malley S, Hamedi-Sangsari F, Vila J (1996). Pilot Clinical Trial of the Combination of Hydroxyurea and Didanosine in HIV-1 Infected Individuals. Antiviral Research 29, 111-113.

Bahlman W (1996). Innovative Combination Clinical Trial Designs/Patient Compliance: A Community Perspective. Antiviral Research 29, 115-117.

McLaren C, Elkins M, Salgo M, Myers M, Benoit S, Warburg M (1996). Intercompany Collaboration for AIDS Drug Development: Perspective on Combination Studies. Antiviral Research 29, 119-122.

Kimberlin DW, Whitley RJ (1995). Antiviral Resistance – An Emerging Problem. Antiviral Research 26, 365-368.

Kimberlin DW, Coen DM, Biron KK, Cohen JI, Lamb RA, McKinlay M, Emini EA, Whitley RJ (1995). Molecular Mechanisms of Antiviral Resistance. Antiviral Research 26, 369-401.

Kimberlin DW, Spector SA, Hill EL, Biron KK, Hay AJ, Mayers DL, Whitley RJ (1995). Assays for Antiviral Drug Resistance. Antiviral Research 26, 403-413.

Kimberlin DW, Kern ER, Sidwell RW, North TW, Whitley RJ (1995). Models of Antiviral Resistance. Antiviral Research 26, 415-422.

Kimberlin DW, Crumpacker CS, Strauss SE, Biron KK, Drew WL, Hayden FG, McKinlay M, Richman DD, Whitley RJ (1995). Antiviral Resistance in Clinical Practice. Antiviral Research 26, 423-438.

Kimberlin DW, Couch RB, Galasso GJ, Richman DD, Whitley RJ (1995). Research Initiatives in Studies of Antiviral Resistance and Consensus Points and Recommendations. Antiviral Research 26, 439-452.